Target type: molecularfunction
Catalysis of the reaction: diphosphate + nicotinamide mononucleotide = 5-phospho-alpha-D-ribose 1-diphosphate + H+ + nicotinamide. [RHEA:16149]
Nicotinamide phosphoribosyltransferase (NAMPT) is an enzyme that catalyzes the synthesis of nicotinamide adenine dinucleotide (NAD+) from nicotinamide and 5-phosphoribosyl 1-pyrophosphate (PRPP). NAD+ is a critical coenzyme involved in various metabolic reactions, including redox reactions, DNA repair, and signal transduction.
NAMPT plays a crucial role in the salvage pathway of NAD+ biosynthesis, which recovers nicotinamide, a breakdown product of NAD+, for NAD+ regeneration. This pathway is particularly important in tissues with high NAD+ demand, such as the brain, liver, and adipose tissue.
The molecular function of NAMPT involves several key steps:
1. **Binding of substrates:** NAMPT binds to both nicotinamide and PRPP, bringing them together in the active site.
2. **Phosphoribosylation:** NAMPT catalyzes the transfer of the phosphoribosyl group from PRPP to nicotinamide, forming nicotinamide mononucleotide (NMN). This reaction is highly specific and requires Mg2+ as a cofactor.
3. **Product release:** NMN is released from the active site of NAMPT, leaving the enzyme ready for another cycle.
4. **Regulation:** NAMPT activity is regulated by various factors, including NAD+ levels, intracellular calcium concentrations, and post-translational modifications.
5. **Cellular localization:** NAMPT can be found in both the cytoplasm and the nucleus, suggesting that it may have different functions in different cellular compartments.
In summary, NAMPT's molecular function is essential for maintaining NAD+ levels, which are crucial for numerous cellular processes. Its activity is tightly regulated and plays a significant role in various physiological and pathological conditions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Nicotinamide phosphoribosyltransferase | A nicotinamide phosphoribosyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43490] | Homo sapiens (human) |
Nicotinamide phosphoribosyltransferase | A nicotinamide phosphoribosyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43490] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ci 994 | tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers. tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells | acetamides; benzamides; substituted aniline | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
diazoxide | diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent |
chs 828 | aromatic ether | ||
stf-31 | STF-31: antineoplastic | ||
fk 866 | N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide: inhibits nicotinamide phosphoribosyltransferase; structure in first source | benzamides; N-acylpiperidine | |
chidamide | benzamides | ||
gne-618 | GNE-618: inhibits nicotinamide phosphoribosyl transferase; structure in first source | ||
gne-617 | GNE-617: inhibits nicotinamide phosphoribosyltransferase; structure in first source |